Edition:
United States

Alexion Pharmaceuticals Inc (ALXN.O)

ALXN.O on Nasdaq

128.22USD
30 Aug 2016
Change (% chg)

-- (--)
Prev Close
$128.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,788,622
52-wk High
$193.45
52-wk Low
$110.56

Reports per page
Select Report Title Date Provider Pgs Price
Trading Report for (ALXN). A detailed report, including free correlated market analysis, and updates. 30 Aug 2016 Stock Traders Daily 6 20.00
ALXN: Due Diligence Review: Forensic Earnings and Valuation 30 Aug 2016 New Constructs, LLC 10 25.00
Thomson Reuters Stock Report - Alexion Pharmaceuticals Inc (ALXN-O) 30 Aug 2016 Thomson Reuters Stock Report 12 25.00
ValuEngine Rating and Forecast Report for ALXN 27 Aug 2016 ValuEngine, Inc. 11 25.00
Alexion Pharmaceuticals 27 Aug 2016 S&P Capital IQ – STARS Reports 11 127.00
ALEXION PHARMACEUTICAL INC (ALXN=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 26 Aug 2016 Pechala's Reports 2 25.00
Alexion Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 26 Aug 2016 Reuters Investment Profile 12 20.00
Validea Guru Analysis Report for ALXN. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. 26 Aug 2016 Validea 0 12.00
Value Graph: ALEXION PHARM -- ALXN 25 Aug 2016 Ford Investor Services, Inc. 1 12.00
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALEXION PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 25 Aug 2016 Jefferson Research 11 20.00
 
Name Age Since Current Position

Leonard Bell

57 2015 Chairman of the Board

David Hallal

49 2015 Chief Executive Officer, Director

Vikas Sinha

52 2012 Chief Financial Officer, Executive Vice President

Clare Carmichael

56 2014 Chief Human Resource Officer, Executive Vice President

John Moriarty

48 2014 Executive Vice President, General Counsel